Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-02-04 @ 9:30 AM
Study NCT ID:
NCT05178134
Status:
COMPLETED
Last Update Posted:
2025-08-19
First Post:
2021-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Sponsor:
Scandinavian Biopharma AB
Organization: